GRFS
Grifols, S.A.
NASDAQ · Healthcare · Drug Manufacturers - General · ES
$7.80
−1.02%Leverage
- Debt / equity
- 1.54x
- Net debt / equity
- 1.44x
- Debt / assets
- 0.42x
- Debt / EBITDA
- 4.87x
- Net debt / EBITDA
- 4.58x
Liquidity & coverage
- Current ratio
- 2.37x
- Quick ratio
- 0.81x
- Cash ratio
- 0.24x
- Interest coverage
- 2.31x
- EBITDA / interest
- 3.26x
- Working capital
- $3.6B
Cash & dividend
- FCF / debt
- 0.08x
- Cash flow / debt
- 0.13x
- Dividend per share
- $0.09
- Dividend yield
- 1.2%
- Dividend growth 1y
- -33.7%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026